Neuronetics (STIM) Tops Q1 EPS by 2c ; Offers Guidance

Neuronetics (NASDAQ: STIM) reported Q1 EPS of ($0.27), $0.02 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $17.4 million versus the consensus estimate of $17.12 million.

GUIDANCE:

Neuronetics sees Q2 2024 revenue of $18-19 million, versus the consensus of $19.46 million.

Neuronetics sees FY2024 revenue of $78-80 million, versus the consensus of $79.12 million.

For earnings history and earnings-related data on Neuronetics (STIM) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Emkay Global Starts Vedanta Aluminium Metal (VAML:IN) at Buy (1)
• Biogen expects $164M R&D charge to hit Q2 2026 earnings